Test License [Regulatives / Guidelines]

posted by wienui  – Germany/Oman, 2018-10-07 23:04 (2419 d 17:37 ago) – Posting: # 19414
Views: 4,930

Dear RK,

❝ I applied Test license for some X drug in India, I got permission and I imported the drug (reference) from outside India then conducted one study (pilot). Now I want to conduct one more study (pivotal) with remaining quantity of Reference drug from first study. Here I have some doubts:


❝ 1) Can I use remaining quantity of reference drug for pivotal

No, You can't use the rest of the reference drug for conducting a BE Study with a new ordered reference drug batch, as they are two different Batches (Biobatches).

❝ 2) If we use remaining IPs, Is we need to get Test license permission for pivotal.


Yes, you will need.

Regards,

Osama

Cheers,
Osama

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,681 registered users;
53 visitors (0 registered, 53 guests [including 33 identified bots]).
Forum time: 16:41 CEST (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body.    Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5